Screening mammography a decade post-tomosynthesis: varied utilization of synthetic mammography across a large health system
British Journal of Radiology · 2025
DOI: 10.1093/bjr/tqaf137 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Radiology, 2025. Verfasst von Xinhua Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, United States. Hauptthemen laut MEDLINE: Mammography, Breast Neoplasms, Early Detection of Cancer. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objectives
Digital breast tomosynthesis (DBT) with 2-dimensional acquisition (2D) was approved in 2011 for breast cancer screening in the United States. To reduce radiation dose to breasts, synthetic mammography (SM) was developed and approved to replace 2D with combo DBT in 2013. This retrospective study of screening practices in a large, incompletely integrated health system, assesses extent of SM utilization, and examines its impact on average glandular dose (AGD).
Methods
Consecutive screening exams on 61 mammography systems at 9 hospitals from February 26 to March 12, 2023, were examined. Data collection included patient exams and radiation exposure. Comprehensive analysis included number of 2D acquisitions, 3-dimensional (3D) views, breast thickness, and AGD. Comparative assessments were made across the health system cohort and individual hospitals. Statistical analysis was performed using the R statistical software (version 4.3.2).
Results
This study included 6849 screening exams on 13 484 breasts (thickness, 5.96 ± 1.47 cm) that received 3D views (13 482/13 484, or 99.99%) and 2D acquisitions (9459/13 484, or 70.15%). For average breast thickness (about 6 cm), mean AGD per breast was 0.29-5.32 mGy (2D only), 4-6.1 mGy (3D only), and 5.5-9.94 mGy (2D/3D). Three hospitals preferentially used SM (81.3%-93.5% of breasts). For an average breast, the ratio of mean AGD(3D) without 2D acquisitions to mean AGD(3D + 2D) with 2D acquisitions was 0.589 (95% CI: 0.561-0.619), 0.625 (0.563-0.702), and 0.588 (0.508-0.696), respectively.
Conclusions
SM reduces AGD. There is a need to review recurring screening mammographic exams, and optimize patient doses by adopting SM, where it meets the clinic’s requirements. Advances in knowledge SM reduces AGD by 36.5%, but only 3 of 9 hospitals within the same large health system have adopted this technology. Breast centres should consider reviewing their imaging protocols to optimize radiation doses for patients undergoing annual screening mammography with SM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, United States.
- Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115, United States.
ORCID-Profile: Xinhua Li
Zitieren
APA
Li, X., Giess, C. S., Chikarmane, S. A., Rehani, M. M., Marschall, T. A., Yang, K., & Liu, B. (2025). Screening mammography a decade post-tomosynthesis: varied utilization of synthetic mammography across a large health system. British Journal of Radiology. https://doi.org/10.1093/bjr/tqaf137
Vancouver
Li X, Giess CS, Chikarmane SA, Rehani MM, Marschall TA, Yang K, et al. Screening mammography a decade post-tomosynthesis: varied utilization of synthetic mammography across a large health system. British Journal of Radiology. 2025. doi:10.1093/bjr/tqaf137
BibTeX
@article{Li2025,
author = {Li, Xinhua and Giess, Catherine S and Chikarmane, Sona A and Rehani, Madan M and Marschall, Theodore A and Yang, Kai and Liu, Bob},
title = {Screening mammography a decade post-tomosynthesis: varied utilization of synthetic mammography across a large health system},
journal = {British Journal of Radiology},
year = {2025},
doi = {10.1093/bjr/tqaf137}
}
EUVIMED